NM_001034853.2(RPGR):c.593G>A (p.Gly198Glu) is a missense variant encoding the substitution of glycine by glutamate at amino acid 198. Another missense variant in the same codon, NM_001034853.2(RPGR):c.592G>A (p.Gly198Arg) (PMIDs: 34985506, 31456290), has been classified as pathogenic for RPGR-related retinopathy based on the ClinGen X-linked IRD VCEP specifications, while no benign missense variants have been identified in this codon. However, the present variant has a lower Grantham’s distance (98) than the comparison variant (125), so the PM5 code has not been applied. This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been reported in at least 2 apparently unrelated probands meeting one of the PS4 requirements of a male with some functional vision impairment by age 30 years and/or decreased or absent electroretinogram responses (PMID: 18552978, PMID: 32821524, PS4_Supporting). At least one proband harboring the variant exhibits a phenotype including diagnosis at age 25 years, extinguished electroretinogram responses from both rods and cones, night blindness (0.5 pts), visual field defects (0.5 pts), and reduced visual acuity (0.5 pts), which together are not sufficiently specific for RPGR-related retinopathy, so PP4 is not met (1.5 points, PMID: 32821524). The computational predictor REVEL gives a score of 0.980, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RPGR function (PP3_Strong). The computational splicing predictor SpliceAI gives a delta score of 0.15 for donor loss, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not strongly predict that the variant disrupts RPGR splicing. In summary, this variant is classified as likely pathogenic for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; PS4_Supporting, PP3_Strong, and PM2_Supporting.